This trial is active and currently recruiting.
Who Can Participate
Adults with non-small cell lung cancer (NSCLC) that was completely removed with surgery who may or may not have received chemotherapy after surgery. Participants cannot have lung cancer that involves a standard anti-cancer treatment at their current stage.
Age: 18+ Gender: Any Gender
Estimated Time Commitment
Up to 12 months
Treatment with the investigational medication or the placebo will last for about 12 months. All participants will be seen at 4 and 12 weeks after the end of the dosing period. Follow-up visits will then occur every 12 weeks for up to two years, then every six months for one year, and annually thereafter. The visits should take about 1.5 hours each. Our researchers would like to keep track of participants’ health for the rest of their lives to see long-term effects of participating in the study.